In development
RCH-01 is an autologous cell therapy in development for pattern hair loss (androgenetic alopecia). It uses dermal sheath cup (DSC) cells isolated from the patient’s own hair follicles.
Dermal sheath cup cells are located at the base of the hair follicle and are involved in regulating the growth of the hair fibre. In androgenetic alopecia, these cells are affected by the hormone DHT in balding areas of the scalp. Cells at the back of the scalp are not affected in the same way.
For RCH-01, DSC cells are isolated from a small tissue sample taken from the back of the patient’s scalp, expanded in culture, and injected into affected areas of the scalp.